rupiya.io
⠋Loading...
0%
❯ Fetching dividend history...
Lenskart Solutions Ltd is a Medical Instruments & Supplies company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Lenskart Solutions Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Instruments & Supplies. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Create a free account to view momentum, moving averages, and delivery signals.
Upgrade to view volatility, drawdown, factor, and risk metrics.
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | ₹905 Cr | ₹1,503 Cr | ₹3,788 Cr | |
| Expenses | ₹952 Cr | ₹1,617 Cr | ₹3,524 Cr | |
| Operating Profit | ₹-47 Cr | ₹-115 Cr | ₹264 Cr | |
| OPM % | -5.0% | -8.0% | 7.0% | |
| Other Income | ₹127 Cr | ₹116 Cr | ₹140 Cr | |
| Depreciation | ₹39 Cr | ₹85 Cr | ₹418 Cr | |
| Interest | ₹7 Cr | ₹23 Cr | ₹83 Cr | |
| Profit Before Tax | ₹33 Cr | ₹-108 Cr | ₹-97 Cr | |
| Tax | ₹33 Cr | ₹-108 Cr | ₹-97 Cr | |
| Net Profit | ₹29 Cr | ₹-102 Cr | ₹-64 Cr | |
| EPS (₹) | 3.8 | -13.4 | -8.3 | |
| Dividend Payout % | 0% | 0% | 0% |
Register free to see 1 more year.
| Quarter | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | ₹1,736 Cr | ₹1,669 Cr | ₹1,894 Cr | ₹2,096 Cr |
| Expenses | ₹1,449 Cr | ₹1,459 Cr | ₹1,558 Cr | ₹1,683 Cr |
| Operating Profit | ₹286 Cr | ₹210 Cr | ₹336 Cr | ₹413 Cr |
| OPM % | 16.0% | 13.0% | 18.0% | 20.0% |
| Depreciation | ₹196 Cr | ₹199 Cr | ₹237 Cr | ₹253 Cr |
| Interest | ₹26 Cr | ₹34 Cr | ₹41 Cr | ₹45 Cr |
| Net Profit | ₹86 Cr | ₹2 Cr | ₹61 Cr | ₹103 Cr |
| EPS (₹) | 11.1 | 0.0 | 0.8 | 1.2 |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹15 Cr | ₹15 Cr | ₹15 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹2,363 Cr | ₹2,918 Cr | ₹5,441 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹30 Cr | ₹34 Cr | ₹934 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹393 Cr | ₹733 Cr | ₹3,071 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹2,802 Cr | ₹3,700 Cr | ₹9,462 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹337 Cr | ₹649 Cr | ₹5,067 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹841 Cr | ₹1,048 Cr | ₹787 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹1,618 Cr | ₹1,869 Cr | ₹3,474 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹2,802 Cr | ₹3,700 Cr | ₹9,462 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Register free to see 1 more year.
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| Mar 2022 | ₹-117 Cr | ₹115 Cr | ₹-16 Cr | — |
| Mar 2023 | ₹-183 Cr | ₹-421 Cr | ₹604 Cr | — |
| Mar 2024 | ₹95 Cr | ₹-2,586 Cr | ₹2,777 Cr | — |
| Mar 2025 |
Register free to see 1 more year.
No dividend history available.
No corporate actions recorded.
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹14,010 Cr | 111.6 | 0.00% | -10.59% |
| Fabtech Technologies Ltd | ₹669 Cr | 15.0 | +12.94% | -37.68% |
| Fischer Medical Ventures Ltd | ₹2,284 Cr | 59.2 | 0.00% | -51.94% |
| Inventurus Knowledge Solutions Ltd | ₹26,681 Cr | 37.7 | 0.00% | -3.62% |
| Indegene Ltd | ₹12,256 Cr | 28.0 | +13.94% | +0.28% |
Create a free account to see institutional ownership snapshots.
Create a free account to view recent director and promoter trades.
Create a free account to view recent institutional deal activity.
Create a free account to view analyst estimate summaries.
Create a free account to view ESG risk and governance summaries.
Upgrade to view issuer ratings, instruments, outlooks, and rating history.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.